Literature DB >> 9758714

Molecular basis of hyperargininemia: structure-function consequences of mutations in human liver arginase.

D E Ash1, L R Scolnick, Z F Kanyo, J G Vockley, S D Cederbaum, D W Christianson.   

Abstract

Hyperargininemia is a rare autosomal recessive disorder that results from a deficiency of hepatic type I arginase. At the genetic level, this deficiency in arginase activity is a consequence of random point mutations throughout the gene that lead to premature termination of the protein or to substitution mutations. Given the high degree of sequence homology between human liver and rat liver enzymes, we have mapped both patient and nonpatient mutations of the human enzyme onto the structure of the rat liver enzyme to rationalize the molecular basis for the low activities of these mutant arginases. Mutations identified in hyperargininemia patients affect the structure and function of the enzyme by compromising active-site residues, packing interactions in the protein scaffolding, and/or quaternary structure by destabilizing the assembly of the arginase trimer. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758714     DOI: 10.1006/mgme.1998.2677

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  10 in total

1.  Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection .

Authors:  Daniel P Dowling; Monica Ilies; Kellen L Olszewski; Silvia Portugal; Maria M Mota; Manuel Llinás; David W Christianson
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

Review 2.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

Review 3.  Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency.

Authors:  Fernando Scaglia; Brendan Lee
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

4.  The effect of liver transplantation for argininemia-the largest experiences in a single center.

Authors:  Bin Cui; Lin Wei; Li-Ying Sun; Wei Qu; Zhi-Gui Zeng; Ying Liu; Zhi-Jun Zhu
Journal:  Transl Pediatr       Date:  2022-04

Review 5.  The human arginases and arginase deficiency.

Authors:  R Iyer; C P Jenkinson; J G Vockley; R M Kern; W W Grody; S Cederbaum
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

6.  Inactivation of human liver arginase by Woodward's reagent K: evidence for reaction with His141.

Authors:  Nelson Carvajal; Elena Uribe; Vasthi López; Mónica Salas
Journal:  Protein J       Date:  2004-04       Impact factor: 2.371

Review 7.  Evolution of the arginase fold and functional diversity.

Authors:  D P Dowling; L Di Costanzo; H A Gennadios; D W Christianson
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

8.  Mouse model for human arginase deficiency.

Authors:  Ramaswamy K Iyer; Paul K Yoo; Rita M Kern; Nora Rozengurt; Rosemarie Tsoa; William E O'Brien; Hong Yu; Wayne W Grody; Stephen D Cederbaum
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 9.  Contrasting features of urea cycle disorders in human patients and knockout mouse models.

Authors:  Joshua L Deignan; Stephen D Cederbaum; Wayne W Grody
Journal:  Mol Genet Metab       Date:  2007-10-22       Impact factor: 4.797

Review 10.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.